Benign thyroid disease is associated with breast cancer: A meta-analysis

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 1169-1177

  Hardefeldt, Prue J ^a   Eslick, Guy D ^a   Edirimanne, Senarath ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Autoimmune thyroiditis; Breast cancer; Goitre; Meta analysis; Thyroid antibody

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; GOITER; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; META ANALYSIS (TOPIC); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; THYROID DISEASE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BREAST NEOPLASMS; FEMALE; GOITER; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; ODDS RATIO; THYROID DISEASES; THYROIDITIS, AUTOIMMUNE;

EID: 84863728740     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2019-3     Document Type: Article

References (54)

1. Sarlis N, Gourgiotis L, Pucino F, Tolis G (2002) Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones 1:35-41
2. Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990-994
3. Gogas J, Kouskos E, Tseleni-Balafouta S et al (2001) Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 27:626-630
4. Jiskra J, Barkmanova J, Limanova Z et al (2007) Thyroid auto-immunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival. Oncol Rep 18:1603-1611
5. Jiskra J, Limanova Z, Barkmanova J, Friedmannova Z (2003) Prevalence of autoimmune thyroid diseases in women with breast cancer in comparison with colorectal cancer. Klin Onkol 16:149-153
6. Cristofanilli M, Yamamura Y, Kau S-W et al (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122-1128
7. Kuijpens JLP, Nyklictek I, Louwman MWJ, Weetman TAP, Pop VJM, Coebergh JWW (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15:1253-1259
8. Singh LS, Lall BN, Agarwall GN (1982) Thyroid in breast cancer. Asian Med J 25:157-163
9. Adami HO, Rimsten A, Thoren L, Vegelius J, Wide L (1978) Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand 144:89-97
10. Ditsch N, Liebhardt S, Von Koch F et al (2010) Thyroid function in breast cancer patients. Anticancer Res 30:1713-1717
11. Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O'Higgins NJ (1996) A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab 81:937-941
12. Adamopoulos DA, Vassilaros S, Kapolla N (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125-128
13. Turken O, NarIn Y, DemIrbas S et al (2003) Breast cancer in association with thyroid disorders. Breast Cancer Res 5:5
14. Dohan O, De La Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter C, Carrasco N (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77
15. Nogueira CR, Brentani MM (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59:271-279
16. Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759-1762
17. Tavangar SM, Monajemzadeh M, Larijani B, Haghpanah V (2007) Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J 48:744-747
18. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
19. Mittra I, Perrin J, Kumaoka S (1976) Thyroid and other autoan-tibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J 1:257-259
20. Sandhu MK, Brezden-Masley C, Lipscombe LL, Zagorski B, Booth GL (2009) Autoimmune hypothyroidism and breast cancer in the elderly. Breast Cancer Res Treat 115:635-641
21. Simon MS, Tang M-TC, Bernstein L et al (2002) Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev 11:1574-1578
22. Fukuda A, Hirohata T, Noguchi S, Ikeda M, Matsuo K, Yoshida A (1987) Risks for malignancies in patients with chronic thy-roiditis: a long-term follow-up study. Jpn J Cancer Res 78:1329-1334
23. Hedley AJ, Jones SJ, Spiegelhalter DJ et al (1981) Breast cancer in thyroid disease: fact or fallacy? Lancet 1:131-133
24. Itoh K, Maruchi N (1975) Breast cancer in patients with Hashimoto's thyroiditis. Lancet 2:1119-1121
25. Muller I, Pinchera A, Fiore E et al (2010) High prevalence of breast cancer in patients with benign thyroid diseases. J Endo-crinol Invest 1:1
26. Goldman MB, Monson RR, Maloof F (1992) Benign thyroid diseases and the risk of death from breast cancer. Oncology 49:461-466
27. Maruchi N, Annegers JF, Kurland LT (1976) Hashimoto's thy-roiditis and breast cancer. Mayo Clin Proc 51:263-265
28. Smyth PP (1993) Thyroid disease and breast cancer. J Endocrinol Invest 16:396-401
29. Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645-649
30. Smyth PP, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711-2716
31. Rasmusson B, Feldt-Rasmussen U, Hegedus L, Perrild H, Bech K, Hoier-Madsen M (1987) Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 23:553-556
32. Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22:1000-1009
33. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699-1703
34. Brinton LA, Hoffman DA, Hoover R, Fraumeni JF Jr (1984) Relationship of thyroid disease and use of thyroid supplements to breast cancer risk. J Chronic Dis 37:877-893
35. Finley JW, Bogardus GM (1960) Breast cancer and thyroid disease. Q Rev Surg Obstet Gynecol 17:139-147
36. Grodecka-Gazdecka S, Lacka K, Graja T, Wawrzyniak M (2004) Examination of the breast in women treated for nodular thyroid disorders. Rep Pract Oncol Radiother 9:105-108
37. Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29:1607-1610
38. Goldman MB, Monson RR, Maloof F (1990) Cancer mortality in women with thyroid disease. Cancer Res 50:2283-2289
39. Backwinkel K, Jackson AS (1964) Some features of breast cancer and thyroid deficiency. Report of 280 cases. Cancer 17:1174-1176
40. Kataoka T, Nishiki M, Yamane M, Amano K, Okumichi T, Ezaki H (1984) Thyroid disease and breast cancer. Hiroshima J Med Sci 33:487-492
41. Hellevik AI, Asvold BO, Bjoro T, Romundstad PR, Nilsen TIL, Vatten LJ (2009) Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 18:570-574
42. Kalache A, Vessey MP, McPherson K (1982) Thyroid disease and breast cancer: findings in a large case-control study. Br J Surg 69:434-435
43. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk in patients hospitalised for Graves disease: a population-based cohort study in Sweden. Br J Cancer 102:1397-1399
44. Purde M, Tekkel M, Hint E, Pleško I, Dimitrova E, Kramarova E, Cichy A, Vlasak V, Linhartova M (1990) Comparative study of breast cancer risk factors in Estonia and Slovakia. Neoplasma 37: 97-104
45. Cengiz O, Bozkurt B, Unal B et al (2004) The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 87:19-25
46. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26:781-785
47. MacFarlane IA, Robinson EL, Bush H et al (1980) Thyroid function in patients with benign and malignant breast disease. Br J Cancer 41:478-480
48. Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761-765
49. Schottenfeld D (1968) The relationship of breast cancer to thyroid disease. J Chronic Dis 21:303-313
50. Weiss HA, Brinton LA, Potischman NA et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816-823
51. Fisher DA, Oddie TH, Johnson DE, Nelson JC (1975) The Diagnosis of Hashimoto's Thyroiditis. J Clin Endocrinol Metab 40:795-801
52. Smyth PPA (2003) Role of iodine in antioxidant defence in thyroid and breast disease. BioFactors 19:121-130
53. Tazebay U, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta P, Fineberg S, Pestell R, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878
54. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, Morris JC (2000) Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60:6526-6530